Client Extranet
|
Site Map
|
RSS
About Us
Practices
People
Offices
News & Insights
Careers
Blogger
Delicious
Digg
Facebook
LinkedIn
Twitter
Email
Home
»
People
»
Robert M Keenan III
» News
Robert M Keenan III (Rob)
Partner
ATLANTA
T: +1 404 572 3591
F: +1 404 572 5100
E-mail
CLOSE
[x]
All Offices
Abu Dhabi
Atlanta
Austin
Charlotte
Dubai
Frankfurt
Geneva
Houston
London
Moscow
New York
Paris
Riyadh
San Francisco
Silicon Valley
Singapore
Washington, D.C.
All Practices
Antitrust
Antitrust & IP
Antitrust Counseling
Antitrust Energy
Cartel Litigation
Civil Antitrust Litigation
EU Competition
Healthcare Antitrust
M&A / Joint Ventures
Pharma Antitrust Solutions
UK Competition and Regulatory
Appellate Litigation
Asian Practice
Asset Management
Bankruptcy/Restructuring
Climate Change
Commercial Disputes
Congressional Investigations
Construction and Procurement
Construction Litigation
Consumer Class Action
Copyright
Corporate Espionage & Competitive Intelligence
Corporate Finance
Corporate Governance
Corporate Plaintiffs Litigation
D&O Liability Litigation
Domestic Arbitration/ADR
E-Commerce
E-Discovery
Emerging Growth
Employee Benefits & Executive Compensation
Energy & Natural Resources
Arbitration
Construction and Procurement
Construction Dispute Resolution
Environmental Litigation
Finance
Financial Restructuring
Foreign Corrupt Practices Act
Intellectual Property
LNG
Maritime
Mergers and Acquisitions
Mining and Natural Resources
Nuclear
Oil & Gas
Oil & Gas Exploration and Production
Oil & Gas Litigation
Oil & Gas Midstream and Pipelines
Oil & Gas Oil Field Services
Oil & Gas Refining
Petrochemical
Power
Power Litigation
Private Equity
Project Development
Regulatory
Renewable/Alternative Energy
Tax
Tort Litigation
Environmental
Environmental Litigation
ERISA & Employee Benefits Litigation
FDA & Life Sciences
Financial Markets
Distressed Assets
Financial Markets Policy
Subprime and Capital Markets
Financial Services
Financial Services Litigation
First Amendment/Defamation
Franchise & Distribution
Franchise & Distribution Litigation
German Practice
Government Advocacy & Public Policy
Political Law
Healthcare Industry
Academic Medical Centers
Antitrust
Children’s Health
Civil Litigation
Class Actions
Clinical Research Compliance
Financial Restructuring
Government Advocacy/Public Policy
Government Investigations/FCA
Health Information Privacy & Security
Healthcare M&A
Healthcare Reform Task Force
Information Technology/EHRs
International Healthcare
Labor & Employment
Managed Care, Health Plans and Insurers
Private Equity
Provider Representation
RAC & MIC Audits and Appeals
Regulatory and Compliance
Reimbursement
Tax
Tax Exempt Bond Financings
Healthcare Litigation
Homeland Security
Infrastructure Finance
Insurance Coverage and Recovery
Intellectual Property
International
International Arbitration
International Trade/WTO
Islamic Finance
Arbitration
Asset Finance
Energy
Healthcare
Middle East & North Africa
Petrochemicals and Refining
Power and Water
Private Equity
Private Equity/Investment Funds
Project Finance
Projects and Construction
Real Estate
Saudi Arabia Practice
Joint Ventures / Strategic Alliances
Labor & Employment
Latin America Practice
Licensing
Marketing & Advertising Litigation
Mass Tort
Mergers & Acquisitions
Our Approach to Litigation
Outsourcing
Patents
Pharma/Biotech/Med Devices
Antitrust
Business Litigation
Corporate
Emerging Companies
Government Advocacy
Government Investigations
Intellectual Property
International Arbitration
Labor & Employment
Products Liability/Mass Tort
Privacy & Information Security
Private Equity/Investment Funds
Private Finance
Product Liability Litigation
Professional Liability Litigation
Project & Equipment Finance
Public Finance
Real Estate
Russia Practice
Securities Litigation/D&O Liability
Special Matters/Government Investigations
Sports, Media & Entertainment
Tax
Tax Litigation
Tax-Exempt
Technology Transactions
Telecommunications
Toxic Tort Litigation
Trade Secrets & Non-Compete Litigation
Trademarks/False Advertising
Advanced Search
Profile
|
News & Insights
NEWS
Go to Page
27 Feb 2012
RECOGNITION
Super Lawyers Magazine Counts 84 King & Spalding Lawyers Among Georgia’s Finest
02 Feb 2012
DEAL NEWS
King & Spalding Advises BioScrip in Sale of Specialty Pharmacies and Centralized Specialty and Mail Service Pharmacy
31 Aug 2011
RECOGNITION
King & Spalding Lawyers Earn 203 Listings in 2012 Best Lawyers in America Guide
13 Jun 2011
RECOGNITION
King & Spalding Earns 36 Practice Rankings and 114 Individual Lawyer Recognitions in 2011 Chambers USA Guide
02 Mar 2011
THOUGHT LEADERSHIP
Twentieth Annual King & Spalding Health Law Forum To Address Healthcare Reform, Accountable Care Organizations
28 Feb 2011
RECOGNITION
Eighty-Two King & Spalding Lawyers Counted Amongst Georgia’s Best in “Super Lawyers” Magazine
09 Jun 2010
DEAL NEWS
King & Spalding Advises Eclipsys in $1.3 Billion Healthcare IT Merger
16 Mar 2010
RECOGNITION
83 at King & Spalding Recognized As 'Georgia Super Lawyers' and 35 as ‘Georgia Rising Stars’
10 Mar 2010
THOUGHT LEADERSHIP
Healthcare Executives to Discuss Latest Legal, Regulatory and Public Policy Developments at 19th Annual King & Spalding...
07 Jan 2010
THOUGHT LEADERSHIP
King & Spalding Plays Significant Role at HCCA Southeast Annual Conference
21 Dec 2009
THOUGHT LEADERSHIP
King & Spalding Leads Active Role at Southeastern Health Care Fraud Institute
12 Jun 2009
RECOGNITION
|
Chambers USA
King & Spalding Lawyers Earn 120 Spots In Chambers USA 2009 Rankings
06 Mar 2009
RECOGNITION
79 at King & Spalding Recognized As 'Georgia Super Lawyers' and 20 as ‘Georgia Rising Stars’
26 Jan 2009
THOUGHT LEADERSHIP
Healthcare Leaders Gather at the 18th Annual King & Spalding Health Law and Policy Forum
17 Sep 2008
RECOGNITION
|
Best Lawyers in America
116 King & Spalding Lawyers Named in 2009 Best Lawyers in America Guide
07 Mar 2008
DEAL NEWS
King & Spalding Represents Arcapita in $395 Million TLC Acquisition
28 Feb 2008
RECOGNITION
|
Georgia Super Lawyers
Seventy King & Spalding Lawyers Named to 2008 'Georgia Super Lawyers' List
04 Sep 2007
RECOGNITION
|
Best Lawyers in America
102 King & Spalding Lawyers Named in 2008 Best Lawyers in America Guide
06 Nov 2006
DEAL NEWS
King & Spalding Advises Per Se Technologies, Inc. On It's $1.8 Billion Sale To McKesson Corporation
05 Sep 2006
RECOGNITION
|
Best Lawyers in America
103 King & Spalding Lawyers Selected for Best Lawyers in America
30 Aug 2005
DEAL NEWS
King & Spalding Advises Per-Se Technologies in its $1 Billion Acquisition of NDCHealth Corporation
11 Aug 2005
RECOGNITION
|
Best Lawyers in America
81 King & Spalding Lawyers Selected for Best Lawyers in America
13 Jan 2005
PRESS RELEASE
King & Spalding LLP Announces 20 New Partners
Go to Page
PRACTICE AREAS
Healthcare Industry
Healthcare M&A
Health Information Privacy & Security
Healthcare Reform Task Force
Healthcare Private Equity
Provider Representation
Healthcare Regulatory
Healthcare Reimbursement
Joint Ventures
Managed Care
Mergers & Acquisitions
EDUCATION
J.D.,
cum laude
, University of Georgia
B.S.,
high honors
, University of Illinois
ADMISSIONS
Georgia
